Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:37
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 50 条
  • [41] Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma
    Shimada, Hideaki
    Shiratori, Tooru
    Yasuraoka, Mari
    Kagaya, Akiko
    Kuboshima, Mari
    Nomura, Fumio
    Takiguchi, Masaki
    Ochiai, Takenori
    Matsubara, Hisahiro
    Hiwasa, Takaki
    BMC CANCER, 2009, 9
  • [42] Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma
    Kagaya, Akiko
    Shimada, Hideaki
    Shiratori, Tooru
    Kuboshima, Mari
    Nakashima-Fujita, Kazue
    Yasuraoka, Mari
    Nishimori, Takanori
    Kurei, Shunsuke
    Hachiya, Takahisa
    Murakami, Akihiro
    Tamura, Yutaka
    Nomura, Fumio
    Ochiai, Takenori
    Matsubara, Hisahiro
    Takiguchi, Masaki
    Hiwasa, Takaki
    PROTEOME SCIENCE, 2011, 9
  • [43] Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival
    Li, Bing-Xin
    Yu, Qi
    Shi, Ze-Liang
    Li, Ping
    Fu, Shen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7241 - 7250
  • [44] Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma
    He, Fu-Cheng
    Meng, Wei-Wei
    Qu, Yun-Hui
    Zhou, Ming-Xia
    He, Jing
    Lv, Pin
    Ming, Liang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) : 4660 - 4665
  • [45] Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOF-MS assay
    Jia, Kun
    Li, Wei
    Wang, Feng
    Qu, Haixia
    Qiao, Yuanyuan
    Zhou, Lanping
    Sun, Yulin
    Ma, Qingwei
    Zhao, Xiaohang
    ONCOTARGET, 2016, 7 (17) : 23569 - 23580
  • [46] Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients
    Yan, Yan
    Wang, Xuan
    Veno, Morten T.
    Bakholdt, Vivi
    Sorensen, Jens A.
    Krogdahl, Annelise
    Sun, Zheng
    Gao, Shan
    Kjems, Jorgen
    ONCOTARGET, 2017, 8 (05) : 8206 - 8214
  • [47] Biomarkers predicting the response to chemotherapy and the prognosis in patients with esophageal squamous cell carcinoma
    Inoue, Seiya
    Yoshida, Takahiro
    Nishino, Takeshi
    Goto, Masakazu
    Aoyama, Mariko
    Kawakita, Naoya
    Yamamoto, Yota
    Yoshihito, Furukita
    Takizawa, Hiromitsu
    Tangoku, Akira
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2021, 69 (03) : 525 - 533
  • [48] Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation
    Wang, Xiao-chun
    Zhang, Zhu-Bo
    Wang, Yue-Ying
    Wu, Hong-Ying
    Li, De-Guan
    Meng, Ai-Min
    Fan, Fei-Yue
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (03) : 401 - 408
  • [49] Identification of a three-gene prognostic signature for radioresistant esophageal squamous cell carcinoma
    Wang, Xiao-Yan
    Beeraka, Narasimha M.
    Xue, Nan-Nan
    Yu, Hui-Ming
    Yang, Ya
    Liu, Mao-Xing
    Nikolenko, Vladimir N.
    Liu, Jun-Qi
    Zhao, Di
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (01):
  • [50] RNA-sequencing based identification of crucial genes for esophageal squamous cell carcinoma
    Fu, Jian-Hua
    Wang, Li-Quan
    Li, Tao
    Ma, Guo-Jun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (02) : 420 - 425